VEEV Stock Veeva Systems Inc.
US · NYSELast in our picks 2026-10-24 — not in the current list; analysis below is from that screen
Life-science software remains structurally attractive, though current targets imply limited upside.
Future value: $298.70 (-7.53%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Strong growth profile is offset by analyst target below recent valuation.
- ▸Above 50-day MA (+16.65%)
- ▸Above 200-day MA — long-term uptrend
- ▸Near 52-week high (98.3% of range) — strength
- ▾Trading above its price target — limited upside
Is VEEV a buy right now?
Trend: VEEV is trading above the 50-day average (+14.19%), RSI 45 — neutral momentum, with a 3-month return of +58.01%.
Valuation & quality: Veeva Systems Inc. trades on a trailing P/E of 52.1, forward P/E 31.0, PEG 1.25, price-to-book 6.92; fundamentals show net margin 29.3%, return on equity 14.4%, revenue growth 17.6% year on year.
Analyst consensus: 27 analysts have a mean 12-month price target of $300.56 (-5.5% vs the last close; range $180.00 – $360.00), consensus rating “buy”.
Our screen: ACCUMULATE (score 1) — Life-science software remains structurally attractive, though current targets imply limited upside.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -3.50% | -11.20% | +11.80% | +1.80% | +14.80% | +40.20% | -0.10% | +11.40% |
Fundamentals
Analyst price target
Technical signals
About Veeva Systems Inc.
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
Sector: Healthcare · Industry: Health Information Services · United States · 7,928 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.